Cited by 433Gut microbiota and healthGastrointestinal motility and disordersMicroscopic Colitis

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea‐predominant irritable bowel syndrome

Open access

Carroll, I. M., Ringel‐Kulka, T., Siddle, J. P., Ringel, Y.·2012·Neurogastroenterology & Motility

DOI 10.1111/j.1365-2982.2012.01891.xPMC PMC3975596

Open this paper in CoChat — free account

Abstract

Background The intestinal microbiota has been implicated in the pathophysiology of irritable bowel syndrome (IBS). Due to the variable resolutions of techniques used to characterize the intestinal microbiota, and the heterogeneity of IBS, the defined alterations of the IBS intestinal microbiota are inconsistent. We analyzed the composition of the intestinal microbiota in a defined subgroup of IBS patients (diarrhea‐predominant IBS, D‐IBS) using a technique that provides the deepest characterization available for complex microbial communities. Methods Fecal DNA was isolated from 23 D‐IBS patients and 23 healthy controls (HC). Variable regions V1–V3 and V6 of the 16S rRNA gene were amplified from all samples. PCR products were sequenced using 454 high throughput sequencing. The composition, diversity and richness of microbial communities were determined and compared between D‐IBS and HC using the quantitative insights into microbial ecology pipeline. Key Results The contribution of bacterial groups to the composition of the intestinal microbiota differed between D‐IBS and HC. D‐IBS patients had significantly higher levels of Enterobacteriaceae (P = 0.03), and lower levels of Fecalibacterium genera (P = 0.04) compared to HC. β‐Diversity values demonstrated significantly lower levels of UniFrac distances in HC compared to D‐IBS patients. The richness of 16S rRNA sequences was significantly decreased in D‐IBS patients (P < 0.04). Conclusions & Inferences Our 16S rRNA sequence data demonstrates a community‐level dysbiosis in D‐IBS. The altered composition of the intestinal microbiota in D‐IBS is associated with significant increases in detrimental and decreases in beneficial bacterial groups, and a reduction in microbial richness.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2982.2012.01891.x

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 21,098
Naive Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 20,145
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Bergey's Manual of Determinative Bacteriology
S., F. A., Buchanan, R. E., Gibbons, N. E., & Bergey (1975) · Taxon · doi:10.2307/1218353 · Cited by 11,304
UniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277

Flagged first, then by citations

Show all 63 references

Research works printed but not linked: 1

Ringel Y, 2008, Netter’s Textbook of Internal Medicine, 419

Sorted by citations

Items 101–200 of 433

Relationship between mucosa-associated gut microbiota and human diseases
Juge, N. (2022) · Biochemical Society Transactions · doi:10.1042/bst20201201 · Cited by 98
Microbiome-Driven Therapeutics: From Gut Health to Precision Medicine
Yaqub, M. O., Jain, A., Joseph, C. E., & Edison, L. K. (2025) · Gastrointestinal Disorders · doi:10.3390/gidisord7010007 · Cited by 100
Interactions between NSAIDs, opioids and the gut microbiota - Future perspectives in the management of inflammation and pain
Zádori, Z., Király, K. P., Al‐Khrasani, M., & Gyires, K. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108327 · Cited by 92
Gut microbiota dysbiosis enhances migraine-like pain via TNFα upregulation
Tang, Y., Liu, S., Shu, H., Yanagisawa, L., & Tao, F. (2020) · Molecular Neurobiology · doi:10.1007/s12035-019-01721-7 · Cited by 88
Characteristics of the bacterial microbiome in association with common intestinal parasites in irritable bowel syndrome
Krogsgaard, L. R., Andersen, L. O., Johannesen, T. B., Engsbro, A. L., Stensvold, C. R., Nielsen, H. V., & Bytzer, P. M. (2018) · Clinical and Translational Gastroenterology · doi:10.1038/s41424-018-0027-2 · Cited by 88
The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study
Skrzydło-Radomańska, B., Prozorow-Król, B., Cichoż‐Lach, H., Majsiak, E., Bierła, J. B., Kanarek, E., Sowińska, A., & Cukrowská, B. (2021) · Nutrients · doi:10.3390/nu13030756 · Cited by 93
Pathogenesis and post-infectious complications in giardiasis
Allain, T., & Buret, A. G. (2019) · Advances in Parasitology/Advances in parasitology · doi:10.1016/bs.apar.2019.12.001 · Cited by 93
Efficacy ofBifidobacterium infantis 35624in patients with irritable bowel syndrome: a meta-analysis
Yuan, F., Ni, H., Asche, C. V., Kim, M., Walayat, S., & Ren, J. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1292230 · Cited by 93
Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications
Napolitano, M., Fasulo, E., Ungaro, F., Massimino, L., Sinagra, E., Danese, S., & Mandarino, F. V. (2023) · Microorganisms · doi:10.3390/microorganisms11102369 · Cited by 100
The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease
Inczefi, O., Bacsúr, P., Resál, T., Keresztes, C., & Molnár, T. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.718710 · Cited by 90
Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?
Quigley, E. M. M. (2015) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15621230 · Cited by 89
Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome
Durbán, A., Abellán, J. J., Jiménez-Hernández, N., Artacho, A., Garrigues, V., Ortiz, V., Ponce, J., Latorre, A., & Moya, A. (2013) · FEMS Microbiology Ecology · doi:10.1111/1574-6941.12184 · Cited by 83
Comparison of the Bacterial Composition and Structure in Symptomatic and Asymptomatic Endodontic Infections Associated with Root-Filled Teeth Using Pyrosequencing
Anderson, A. C., Al‐Ahmad, A., Elamin, F., Jonas, D., Mirghani, Y., Schilhabel, M. B., Karygianni, L., Hellwig, E., & Rehman, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084960 · Cited by 82
Artificial intelligence-based personalized diet: A pilot clinical study for irritable bowel syndrome
Karakan, T., Gündoğdu, A., Alagözlü, H., Ekmen, N., Özgül, S., Tunalı, V., Hora, M., Beyazgül, D., & Nalbantoğlu, Ö. U. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2138672 · Cited by 80
Colonization Resistance: Battle of the Bugs or Ménage à Trois with the Host?
Spees, A. M., Lopez, C. A., Kingsbury, D. D., Winter, S., & Bäumler, A. J. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003730 · Cited by 78
Blastocystis: A Mysterious Member of the Gut Microbiome
Aykur, M., Malatyalı, E., Demirel, F., Koçak, B. C., Gentekaki, E., Tsaousis, A. D., & Al, F. D. (2024) · Microorganisms · doi:10.3390/microorganisms12030461 · Cited by 87
Co-Cultures of Lactobacillus acidophilus and Bacillus subtilis Enhance Mucosal Barrier by Modulating Gut Microbiota-Derived Short-Chain Fatty Acids
Xie, Z., Li, M., Qian, M., Yang, Z., & Han, X. (2022) · Nutrients · doi:10.3390/nu14214475 · Cited by 83
Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea
Pimentel, M. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13437 · Cited by 76
Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial
Matijašić, B. B., Obermajer, T., Lipoglavšek, L., Sernel, T., Locatelli, I., Kos, M., Šmid, A., & Rogelj, I. (2016) · Journal of Dairy Science · doi:10.3168/jds.2015-10743 · Cited by 81
Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome
Żeber‐Lubecka, N., Kulecka, M., Ambrożkiewicz, F., Paziewska, A., Goryca, K., Karczmarski, J., Rubel, T., Wojtowicz, W., Młynarz, P., Marczak, Ł., et al. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1215805 · Cited by 77
Metagenomics of Two Severe Foodborne Outbreaks Provides Diagnostic Signatures and Signs of Coinfection Not Attainable by Traditional Methods
Huang, A. D., Luo, C., Peña, Á., Weigand, M. R., Tarr, C. L., & Konstantinidis, K. T. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.02577-16 · Cited by 79
Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome
Mei, L., Zhou, J., Su, Y., Mao, K., Wu, J., Zhu, C., He, L., & Cui, Y. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01693-w · Cited by 76
Gut Ruminococcaceae levels at baseline correlate with risk of antibiotic-associated diarrhea
Gu, X., Sim, J. X. Y., Lee, W. L., Liang, C., Chan, Y. F. Z., Chang, E. D., Teh, Y. E., Zhang, A., Armas, F., Chandra, F., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103644 · Cited by 79
Unraveling the ties between irritable bowel syndrome and intestinal microbiota
Hong, S. N. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2470 · Cited by 76
Human intestinal metagenomics: state of the art and future
Blottière, H. M., de Vos, W. M., Ehrlich, S. D., & Dore, J. M. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.006 · Cited by 78
Gut Microbiota‐Bile Acid Crosstalk in Diarrhea‐Irritable Bowel Syndrome
Zhan, K., Zheng, H., Jian-qing, L., Wu, H., Qin, S., Luo, L., & Huang, S. (2020) · BioMed Research International · doi:10.1155/2020/3828249 · Cited by 72
Gut Microbiota Patterns Associated with Colonization of Different Clostridium difficile Ribotypes
Škraban, J., Džeroski, S., Ženko, B., Mongus, D., Gangl, S., & Rupnik, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058005 · Cited by 70
Fecal Protease Activity Is Associated with Compositional Alterations in the Intestinal Microbiota
Carroll, I. M., Ringel‐Kulka, T., Ferrier, L., Wu, M. C., Siddle, J. P., Bueno, L. P., & Ringel, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078017 · Cited by 70
Self-citation
The possible role of bacteria, viruses, and parasites in initiation and exacerbation of irritable bowel syndrome
Shariati, A., Fallah, F., Pormohammad, A., Taghipour, A., Safari, H., Chirani, A. S., Sabour, S., Sani, M. A., & Azimi, T. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27828 · Cited by 71
Food Additives, Gut Microbiota, and Irritable Bowel Syndrome: A Hidden Track
Rinninella, E., Cintoni, M., Raoul, P. C., Gasbarrini, A., & Mele, M. C. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17238816 · Cited by 78
Co-factors, Microbes, and Immunogenetics in Celiac Disease to Guide Novel Approaches for Diagnosis and Treatment
Verdu, E. F., & Schuppan, D. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.08.016 · Cited by 78
Intestinal accumulation of microbiota-produced succinate caused by loss of microRNAs leads to diarrhea in weanling piglets
Zhou, X., Liu, Y., Xiong, X., Chen, J., Tang, W., He, L., Zhang, Z., Yin, Y., & Li, F. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2091369 · Cited by 65
Association of altered gut microbiota composition with chronic urticaria
Nabizadeh, E., Jazani, N. H., Bagheri, M., & Shahabi, S. (2017) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2017.05.006 · Cited by 69
Inhibition of corticotropin-releasing hormone receptor 1 and activation of receptor 2 protect against colonic injury and promote epithelium repair
Li, B., Lee, C. M., Filler, T., Hock, A., Wu, R., Li, Q., Chen, S., Koike, Y., Ip, W., Chi, L., et al. (2017) · Scientific Reports · doi:10.1038/srep46616 · Cited by 64
Intestinal Microbiota Predicts Lung Cancer Patients at Risk of Immune-Related Diarrhea
Liu, T., Xiong, Q., Li, L., & Hu, Y. (2019) · Immunotherapy · doi:10.2217/imt-2018-0144 · Cited by 64
Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome
Zhu, S., Liu, S., Li, H., Zhang, Z., Zhang, Q., Chen, L., Zhao, Y., Chen, Y., Gu, J., Min, L., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00346 · Cited by 66
The gut virome in Irritable Bowel Syndrome differs from that of controls
Coughlan, S., Das, A., O’Herlihy, E. A., Shanahan, F., O’Toole, P. W., & Jeffery, I. B. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1887719 · Cited by 63
Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials
Wu, J., Lv, L., & Wang, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.827395 · Cited by 63
Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?
Newberry, F., Hsieh, S.-Y., Wileman, T., & Carding, S. R. (2018) · Clinical Science · doi:10.1042/cs20171330 · Cited by 63
The Role of the Gastrointestinal Microbiota in Visceral Pain
Rea, K., O’Mahony, S. M., Dinan, T. G., & Cryan, J. F. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_115 · Cited by 64
Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases
Sundin, J., Öhman, L., & Simrén, M. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000470 · Cited by 61
Microbiota dysbiosis and its pathophysiological significance in bowel obstruction
Hegde, S., Lin, Y.-M., Golovko, G., Khanipov, K., Cong, Y., Savidge, T., Fofanov, Y., & Shi, X.-Z. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-31033-0 · Cited by 61
Erratum to: the role of Blastocystis sp. and Dientamoeba fragilis in irritable bowel syndrome: a systematic review and meta-analysis
Rostami, A., Riahi, S. M., Haghighi, A. N., Saber, V., Armon, B., & Tabaei, S. J. S. (2017) · Parasitology Research · doi:10.1007/s00436-017-5556-1 · Cited by 60
Collateral Damage: Microbiota-Derived Metabolites and Immune Function in the Antibiotic Era
Lopez, C. A., Kingsbury, D. D., Velazquez, E. M., & Bäumler, A. J. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.07.009 · Cited by 61
Long-term use of ceftriaxone sodium induced changes in gut microbiota and immune system
Guo, Y., Yang, X., Qi, Y., Shu, W., Liu, Y., Tang, S., Huang, R., & Tang, L. (2017) · Scientific Reports · doi:10.1038/srep43035 · Cited by 61
Relationships of Microbiome Markers With Extraintestinal, Psychological Distress and Gastrointestinal Symptoms, and Quality of Life in Women With Irritable Bowel Syndrome
Hollister, E. B., Cain, K. C., Shulman, R. J., Jarrett, M. E., Burr, R. L., Ko, C. W., Zia, J. K., Han, C. J., & Heitkemper, M. M. (2018) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001107 · Cited by 61
Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
Lacy, B. E. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s93698 · Cited by 59
Tuning Expectations to Reality: Don’t Expect Increased Gut Microbiota Diversity with Dietary Fiber
Cantu-Jungles, T. M., & Hamaker, B. R. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.09.001 · Cited by 62
Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating
Ringel-Kulka, T., Benson, A. K., Carroll, I. M., Kim, J., Legge, R. M., & Ringel, Y. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00044.2015 · Cited by 53
Self-citation
Gut microbiota in chronic pain: Novel insights into mechanisms and promising therapeutic strategies
Liu, L., Wu, Q. J., Chen, Y., Ren, H., Zhang, Q., Yang, H., Zhang, W., Ding, T., Wang, S., Zhang, Y., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109685 · Cited by 57
The Intestinal Microbiota and Irritable Bowel Syndrome
Ringel, Y., & Ringel‐Kulka, T. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000418 · Cited by 55
Self-citation
Irritable bowel syndrome: a concise review of current treatment concepts
Wall, G. C., Bryant, G. A., Bottenberg, M. M., Maki, E. D., & Miesner, A. R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i27.8796 · Cited by 56
Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients
Liu, T., Gu, X., Li, L., Li, M., Li, B., Cui, X., & Zuo, X. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01841-4 · Cited by 58
The Gut-Brain Axis in Healthy Females: Lack of Significant Association between Microbial Composition and Diversity with Psychiatric Measures
Kleiman, S. C., Bulik‐Sullivan, E. C., Glenny, E. M., Zerwas, S. C., Huh, E. Y., Tsilimigras, M. C. B., Fodor, A. A., Bulik, C. M., & Carroll, I. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170208 · Cited by 67
Self-citation
The Role of the Gut Microbiota in Sustained Weight Loss Following Roux-en-Y Gastric Bypass Surgery
Fouladi, F., Brooks, A. E., Fodor, A. A., Carroll, I. M., Bulik‐Sullivan, E. C., Tsilimigras, M. C. B., Sioda, M., & Steffen, K. J. (2019) · Obesity Surgery · doi:10.1007/s11695-018-03653-y · Cited by 55
Self-citation
Functional Gastrointestinal Disorders and the Microbiome—What Is the Best Strategy for Moving Microbiome-based Therapies for Functional Gastrointestinal Disorders into the Clinic?
Mars, R. A. T., Frith, M., & Kashyap, P. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.10.058 · Cited by 53
Habitat disturbance influences the skin microbiome of a rediscovered neotropical-montane frog
Jiménez, R. R., Alvarado, G., Sandoval, J., & Sommer, S. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01979-1 · Cited by 53
Beneficial effects of Rifaximin in post‐infectious irritable bowel syndrome mouse model beyond gut microbiota
Jin, Y. T., Ren, X., Li, G., Li, Y., Zhang, L., Wang, H., Qian, W., & Hou, X. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13841 · Cited by 52
Postinfection Irritable Bowel Syndrome
Downs, I. A., Aroniadis, O. C., Kelly, L., & Brandt, L. J. (2017) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000924 · Cited by 56
The microbiome of the oral mucosa in irritable bowel syndrome
Fourie, N. H., Wang, D., Abey, S. K., Sherwin, L. B., Joseph, P. V., Rahim-Williams, B., Ferguson, E. G., & Henderson, W. A. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1162363 · Cited by 53
Daily Changes in Composition and Diversity of the Intestinal Microbiota in Patients with Anorexia Nervosa: A Series of Three Cases
Kleiman, S. C., Glenny, E. M., Bulik‐Sullivan, E. C., Huh, E. Y., Tsilimigras, M. C. B., Fodor, A. A., Bulik, C. M., & Carroll, I. M. (2017) · European Eating Disorders Review · doi:10.1002/erv.2524 · Cited by 49
Self-citation
The neglected role of Blastocystis sp. and Giardia lamblia in development of irritable bowel syndrome: A systematic review and meta-analysis
Abedi, S. H., Fazlzadeh, A., Mollalo, A., Sartip, B., Mahjour, S., Bahadory, S., Taghipour, A., & Rostami, A. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105215 · Cited by 55
Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome
Li, Y., Hong, G., Yang, M. J., Li, G., Jin, Y. T., Xiong, H., Qian, W., & Hou, X. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104936 · Cited by 49
Gastrointestinal symptoms in COVID-19: the long and the short of it
Freedberg, D. E., & Chang, L. (2022) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000876 · Cited by 51
The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge
Mari, A., Baker, F. A., Mahamid, M., Sbeit, W., & Khoury, T. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030685 · Cited by 57
Gut Microbiota-Based Therapies for Irritable Bowel Syndrome
Stern, E., & Brenner, D. M. (2018) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2018.2 · Cited by 50
Of bowels, brain and behavior: A role for the gut microbiota in psychiatric comorbidities in irritable bowel syndrome
Wilmes, L., Collins, J. M., O’Riordan, K. J., O’Mahony, S. M., Cryan, J. F., & Clarke, G. A. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14095 · Cited by 52
Gut microbiome associated with chemotherapy-induced diarrhea from the CapeOX regimen as adjuvant chemotherapy in resected stage III colorectal cancer
Fei, Z., Lijuan, Y., Xi, Y., Wu, W., Jing, Z., Da, M., & Han, S. (2019) · Gut Pathogens · doi:10.1186/s13099-019-0299-4 · Cited by 50
Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double‐blind, placebo‐controlled, multicenter, phase II trial
Choi, C. H., Kwon, J. G., Kim, S. K., Myung, S. ‐., Park, K. S., Sohn, C. ‐., Rhee, P. ‐., Lee, K. J., Lee, O. Y., Jung, H. ‐., et al. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12544 · Cited by 46
Diagnosis and management of functional symptoms in inflammatory bowel disease in remission
Teruel, C. (2016) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v7.i1.78 · Cited by 47
Effect of Dietary Magnesium Content on Intestinal Microbiota of Rats
García-Legorreta, A., Soriano-Pérez, L. A., Flores-Buendía, A. M., Medina‐Campos, O. N., Noriega, L. G., Granados‐Portillo, O., Nambo‐Venegas, R., Tovar, A. R., Mendoza-Vargas, A., Barrera‐Oviedo, D., et al. (2020) · Nutrients · doi:10.3390/nu12092889 · Cited by 46
The Emerging Role of the Gut Virome in Health and Inflammatory Bowel Disease: Challenges, Covariates and a Viral Imbalance
Jansen, D., & Matthijnssens, J. (2023) · Viruses · doi:10.3390/v15010173 · Cited by 43
Are Probiotics or Prebiotics Useful in Pediatric Irritable Bowel Syndrome or Inflammatory Bowel Disease?
Guandalini, S. (2014) · Frontiers in Medicine · doi:10.3389/fmed.2014.00023 · Cited by 45
Rifaximin in irritable bowel syndrome: rationale, evidence and clinical use
Saadi, M., & McCallum, R. W. (2013) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622312472008 · Cited by 44
Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome
Wang, Z., Xu, C., Liu, Y., Wang, X., Zhang, L., Li, M., Zhu, S., Xie, Z., Wang, P., Duan, L.-P., et al. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000192 · Cited by 45
Leveraging 16S rRNA Microbiome Sequencing Data to Identify Bacterial Signatures for Irritable Bowel Syndrome
Liu, Y., Li, W., Yang, H., Zhang, X., Wang, W., Jia, S., Xiang, B., Wang, Y., Miao, L., Zhang, H., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.645951 · Cited by 45
Molecular detection of bacterial contamination in gnotobiotic rodent units
Packey, C. D., Shanahan, M. T., Manick, S., Bower, M., Ellermann, M., Tonkonogy, S. L., Carroll, I. M., & Sartor, R. B. (2013) · Gut Microbes · doi:10.4161/gmic.25824 · Cited by 43
Self-citation
Colonic overexpression of the T‐type calcium channel Cav3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients
Scanzi, J., Accarie, A., Muller, E., Pereira, B., Aissouni, Y., Goutte, M., Joubert‐Zakeyh, J., Picard, E., Boudieu, L., Mallet, C., et al. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12860 · Cited by 43
The Human Microbiome and Probiotics: Implications for Pediatrics
Versalovic, J. A. (2013) · Annals of Nutrition and Metabolism · doi:10.1159/000354899 · Cited by 44
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data
Chen, H., Ou, R., Tang, N., Su, W., Yang, R., Yu, X., Zhang, G., Jiao, J., & Zhou, X. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03953-7 · Cited by 48
Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome
König, J., & Brummer, R. J. (2014) · Beneficial Microbes · doi:10.3920/bm2013.0033 · Cited by 43
Microbiome of Total Versus Live Bacteria in the Gut of Rex Rabbits
Fu, X., Zeng, B., Wang, P., Wang, L., Wen, B., Li, Y., Liu, H., Bai, S., & Jia, G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00733 · Cited by 41
Human gut bifidobacteria inhibit the growth of the opportunistic fungal pathogen Candida albicans
Ricci, L., Mackie, J., Donachie, G. E., Chapuis, A. F., Mezerová, K., Lenardon, M. D., Brown, A. J. P., Duncan, S. H., & Walker, A. W. (2022) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiac095 · Cited by 45
Structural and functional alterations in the colonic microbiome of the rat in a model of stress induced irritable bowel syndrome
Fourie, N. H., Wang, D., Abey, S. K., Creekmore, A. L., Hong, S., Martin, C. G., Wiley, J. W., & Henderson, W. A. (2017) · Gut Microbes · doi:10.1080/19490976.2016.1273999 · Cited by 40
Overfeeding a High-Fat Diet Promotes Sex-Specific Alterations on the Gut Microbiota of the Zebrafish ( Danio rerio )
Navarro-Barrón, E., Hernández, C., Llera‐Herrera, R., Garcı́a-Gasca, A., & Gómez‐Gil, B. (2019) · Zebrafish · doi:10.1089/zeb.2018.1648 · Cited by 42
Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis
Jia, L.-Q., Sun, J.-R., Kong, C.-F., Qu, X.-K., Deng, C., & Lou, Y.-N. (2020) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_384_19 · Cited by 40
Probiotics in Irritable Bowel Syndrome
Quigley, E. M. M. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000348 · Cited by 41
Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome
Singh, P., & Lembo, A. J. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2021.03.003 · Cited by 39
The relationship between gut microbiome and human diseases: mechanisms, predisposing factors and potential intervention
Shabani, M., Ghoshehy, A., Mottaghi, A. M., Chegini, Z., Kerami, A., Shariati, A., & Moghadam, M. T. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1516010 · Cited by 48
The Gut Microbiome in Irritable Bowel Syndrome and Other Functional Bowel Disorders
Ringel, Y. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.09.014 · Cited by 39
Self-citation
Consideration of Gut Microbiome in Murine Models of Diseases
Zhang, C., Franklin, C. L., & Ericsson, A. C. (2021) · Microorganisms · doi:10.3390/microorganisms9051062 · Cited by 40
Management Strategies for Abdominal Bloating and Distension.
Foley, A., Burgell, R., Barrett, J. S., & Gibson, P. R. (2014) · Europe PMC (PubMed Central) · Cited by 38
Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Pathophysiology to Precision Therapeutics
Selvakumar, B., & Samsudin, A. R. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf225 · Cited by 46
Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome (IBS): an evidence-based review
Schmulson, M. J., Bielsa, M. V., Carmona-Sánchez, R., Hernández, A., López‐Colombo, A., López‐Vidal, Y., Peláez‐Luna, M., Remes-Troche, J. M., Tamayo, J. L., & Valdovinos, M. A. (2014) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2014.01.001 · Cited by 38
Fecal Microbiota Transplantation: A Review of Emerging Indications Beyond Relapsing Clostridium difficile Toxin Colitis.
Lee, W. J., Lattimer, L., Stephen, S., Borum, M. L., & Doman, D. B. (2015) · PubMed · Cited by 39
Loss of function dysbiosis associated with antibiotics and high fat, high sugar diet
Miller, A. W., Orr, T. J., Dearing, M. D., & Monga, M. (2019) · The ISME Journal · doi:10.1038/s41396-019-0357-4 · Cited by 38
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report
Caviglia, G. P., Tucci, A., Pellicano, R., Fagoonee, S., Rosso, C., Abate, M. L., Olivero, A., Armandi, A., Vanni, E., Saracco, G. M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082353 · Cited by 40
Viral metagenomic analysis of fecal samples reveals an enteric virome signature in irritable bowel syndrome
Ansari, M., Ebrahimi, M., Fattahi, M. R., Gardner, M., Safarpour, A. R., Faghihi, M. A., & Lankarani, K. B. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01817-4 · Cited by 38
Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children
Guandalini, S., Cernat, E., & Moscoso, D. I. (2014) · Beneficial Microbes · doi:10.3920/bm2014.0067 · Cited by 38
Involvement of shared mucosal‐associated microbiota in the duodenum and rectum in diarrhea‐predominant irritable bowel syndrome
Li, G., Yang, M. J., Jin, Y. T., Li, Y., Qian, W., Xiong, H., Song, J., & Hou, X. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14059 · Cited by 35

Authors: Carroll, I. M., Ringel‐Kulka, T., Siddle, J. P., & Ringel, Y.
Affiliations: University of North Carolina at Chapel Hill (US)
Corresponding author: Ringel, Y.
ORCID: Carroll, I. M.
Ringel‐Kulka, T.
Venue: Neurogastroenterology & Motility
Publisher: Wiley
Published: 2012-02-20
Volume: 24
Issue: 6
Pages: 521
ISSN: 1350-1925 (ISSN-L)
1365-2982
DOI: 10.1111/j.1365-2982.2012.01891.x
PMC: PMC3975596
OpenAlex: W1487811474
Cited by: 425
References: 63
Citations by year: 2026: 12 · 2025: 18 · 2024: 28 · 2023: 30 · 2022: 39 · 2021: 40 · 2020: 33 · 2019: 35 · 2018: 30 · 2017: 32 · 2016: 31 · 2015: 27 · 2014: 37 · 2013: 25 · 2012: 7
FWCI: 12.33
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Neurogastroenterology & Motility (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (R03DK084294, DK075621, K23DK075621, K01DK092330, DK084294)
National Center for Research Resources (UL1RR025747)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
Keywords: diarrhea-predominant irritable bowel syndrome, gut microbiota, dysbiosis, microbial diversity, microbial richness, Enterobacteriaceae, 16S rRNA gene sequencing
MeSH terms: Adult, Aged, Diarrhea, DNA, Bacterial, Feces, Female, Humans, Intestines, Male, Middle Aged, Irritable Bowel Syndrome, Metagenome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea‐predominant irritable bowel syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks